
At Illumina, we strive to offer the best possible technologies and solutions to our customers. By integrating our technology with other best-in-class solutions, we aim to improve workflows, support groundbreaking research, and continue advancing genomics.
The GRAIL acquisition will accelerate the global adoption of NGS-based multi-cancer early detection tests, increase accessibility, and improve patient outcomes.
Learn MoreThe addition of the Emedgene platform will help geneticists and clinicians to diagnose rare disease patients by offering Artificial Intelligence (AI) technologies that provide genomic interpretation at scale.
Learn MoreCloud computing capabilities from BlueBee are expected to lower the cost of storing, sharing, and managing the enormous volumes of data that stream from Illumina sequencing systems.
Lossless genomic data compression technology from Enancio is fast and efficient, and nicely complements other Illumina informatics solutions.
Edico Genome and the DRAGEN Bio-IT platform are helping researchers accelerate sequencing data analysis.
Laboratory information management systems (LIMS) from GenoLogics help increase lab efficiencies and improve workflows.
The incorporation of Nextera technology into the Illumina portfolio simplifies library preparation workflows.
Powerful big-data platforms from NextBio allow customers to aggregate and analyze phenotypic and genomic data.
The acquisition of Verinata supports our goal to provide solutions that will lead to improved reproductive health outcomes.
Acquired in 2007, Solexa established the foundation of our widely adopted sequencing by synthesis technology.
The Illumina DRAGEN Bio-IT Platform, formerly from Edico Genome, provides accurate, ultra-rapid secondary genomic analyses of sequencing data.
Learn MoreOur on-bead tagmentation technology powers fast workflows for optimized library preparation across a range of sequencing applications.
Learn MorePreviously available from Epicentre, Ribo-Zero solutions set the standard for rRNA and globin mRNA depletion.
Learn MoreOur software portfolio includes Clarity LIMS (formerly Genologics), Correlation Engine (formerly NextBio Research), Cohort Analyzer (formerly NextBio Clinical), and more.
Learn MoreThe acquisition of Verinata Health introduced breakthrough NIPT solutions, including the Verifi prenatal test, to Illumina reproductive health offerings.
Learn MoreBlueFuse Multi Software, previously available from BlueGnome, analyzes molecular cytogenetic and in vitro fertilization data, simplifying embryo screening.
Learn More